RHÖN-KLINIKUM AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Bad Neustadt a.d. Saale, 29 July 2009 

Today the Company has been informed by Mr. Münch, chairman of the
Supervisory Board and shareholder of RHÖN-KLINIKUM AG, that he has,
jointly with UniCredit Group (Bayerische Hypo- und Vereinsbank AG) ('HVB'),
placed 15m subscription rights - out of the 16,661,044 subscription rights
he and his wife are entitled to - off the floor in the context of the
current capital increase of RHÖN-KLINIKUM AG. The total price for this
rights issue is EUR 6.3m, corresponding to an average of EUR 0.418 per
subscription right.

The agreement between HVB and the Münch family ultimately results in the
rights issue proceeds being divided by half. HVB had guaranteed minimum
proceeds of approx. EUR 2.362m (one third of the theoretical value of the
subscription rights). Subject to a purchase price adjustment agreement with
HVB, a total of approx. EUR 3.2m (before tax) will accrue to the Münch
family. The Münch family will use the net proceeds (after tax) from the
sale of their subscription rights and further private funds to exercise the
subscription rights they hold and to subscribe to 553,682 new shares (at a
subscription price of EUR 13.30 per share, totalling EUR 7.4m).

If the capital increase is fully implemented, the Münch family will hold a
total interest of 12.45% in the Company.


'These materials are not for distribution, directly or indirectly, in or
into the United States (including its territories and dependencies, any
State of the United States and the District of Columbia). These materials
do not constitute or form a part of any offer or solicitation to purchase
or subscribe for securities. The shares in RHÖN-KLINIKUM AG (the 'Shares')
mentioned herein may not be offered or sold in the United States absent
registration or an exemption from registration under the U.S. Securities
Act of 1933, as amended (the 'Securities Act'). The Shares have not been,
and will not be, registered under the Securities Act and will not be
offered or sold in the United States, except on the basis of applicable
exemptions from registration. There will be no public offering of
securities in the United States or anywhere outside of Germany.'


Dr. Erik Hamann
Member of the Board of Management for Financing, IR, Controlling 
Tel.: (09771) 65-1351 Fax: (09771) 991736
E-mail: vfire@rhoen-klinikum-ag.com 

Dr. Irmgard Stippler
Member of the Board of Management for Communication/IT 
Tel.: (09771) 65-1321 Fax: (09771) 65-1820 
E-mail: kommunikation@rhoen-klinikum-ag.com



29.07.2009  Financial News transmitted by DGAP

 
Language:     English
Issuer:       RHÖN-KLINIKUM AG
              Salzburger Leite 1
              97616 Bad Neustadt a.d.Saale
              Deutschland
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), München;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
 
End of News                                     DGAP News-Service